Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

The Illness of Uncertainty, Personality and Coping Strategies in Patients With Hepatocellular Carcinoma

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT01380392
First received: June 22, 2011
Last updated: June 23, 2011
Last verified: June 2011
  Purpose

The aims of this study are to (1) understand the uncertainty , personality and coping strategies in patients with HCC, and identify the significant factors for coping.


Condition
Liver Carcinoma

Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: The Illness of Uncertainty, Personality and Coping Strategies in Patients With Hepatocellular Carcinoma

Resource links provided by NLM:


Further study details as provided by National Taiwan University Hospital:

Estimated Enrollment: 200
Study Start Date: February 2011
Estimated Study Completion Date: February 2012
Estimated Primary Completion Date: February 2012 (Final data collection date for primary outcome measure)
Detailed Description:

A cross-sectional correlated design will be used and (2) patients will be recruited by purposive sampling from wards and outpatient departments at a medical center in Taipei.

  Eligibility

Ages Eligible for Study:   20 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

HCC patients who accept surgical or medical treatment.

Criteria

Inclusion Criteria:

  • Adult
  • Has HCC and knows condition
  • Con's clear
  • Agree join the study

Exclusion Criteria:e

  • BCLC stage C or D
  • Accepted C/T, R/T,target therapy or supportive care
  • Patient who receive liver transplantation
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01380392

Contacts
Contact: Wu Ruei-Jhu, Master +886933037480 r98426022@ntu.edu.tw

Locations
Taiwan
Research Nurse Recruiting
Taipei, Taiwan, 110
Contact: Wu Ruei-Jhu, Master    +886933037480    r98426022@ntu.edu.tw   
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Study Chair: Shiow-Ching Shun, Doctor National Taiwan University
  More Information

No publications provided

Responsible Party: Shiow-Ching Shun, Department of Nursing,NTU
ClinicalTrials.gov Identifier: NCT01380392     History of Changes
Other Study ID Numbers: 201101063RC
Study First Received: June 22, 2011
Last Updated: June 23, 2011
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
Liver cancer
Uncertainty
Personality
coping strategies

Additional relevant MeSH terms:
Carcinoma
Carcinoma, Hepatocellular
Adenocarcinoma
Digestive System Diseases
Digestive System Neoplasms
Liver Diseases
Liver Neoplasms
Neoplasms
Neoplasms by Histologic Type
Neoplasms by Site
Neoplasms, Glandular and Epithelial

ClinicalTrials.gov processed this record on November 24, 2014